Housing Watch Web Search

Search results

1. Results From The WOW.Com Content Network

2. AstraZeneca's Imfinzi fails in late-stage trial to treat ...

   www.aol.com/news/astrazenecas-imfinzi-fails...

   June 25, 2024 at 3:54 AM. (Reuters) -AstraZeneca's blockbuster cancer drug Imfinzi has failed as a follow-up therapy to improve disease-free survival in a late-stage trial in patients with a type ...

3. AstraZeneca's Imfinzi improves survival in late-stage lung ...

   www.aol.com/news/astrazenecas-imfinzi-shows...

   Imfinzi clocked $4.24 billion in sales in 2023, and is a blockbuster medicine in AstraZeneca's key oncology portfolio, which makes up more than 20% of its total revenues.

4. Pfizer wins $107.5 million from AstraZeneca in US ... - AOL

   www.aol.com/news/pfizer-wins-107-5-million...

   May 17, 2024 at 5:40 PM. By Blake Brittain. (Reuters) - AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung ...

5. List of largest selling pharmaceutical products - Wikipedia

   en.wikipedia.org/wiki/List_of_largest_selling...

   Rank Drug Main indication Trade name 2018 sales (million USD) 2017 sales (million USD) 1 adalimumab: rheumatoid arthritis: Humira 19 936 18427 3 apixaban

6. AstraZeneca - Wikipedia

   en.wikipedia.org/wiki/AstraZeneca

   AstraZeneca plc ( / ˌæstrəˈzɛnəkə /) ( AZ) is a British-Swedish multinational pharmaceutical and biotechnology company [2] [3] [4] with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. [5] It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection ...

7. Amgen - Wikipedia

   en.wikipedia.org/wiki/Amgen

   Amgen Inc. Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. [3] [4] One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total. [5] The name "AMGen" is a portmanteau of the ...

8. Durvalumab - Wikipedia

   en.wikipedia.org/wiki/Durvalumab

   Durvalumab, sold under the brand name Imfinzi, is an FDA-approved immunotherapy for cancer, developed by Medimmune/AstraZeneca. It is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that blocks the interaction of programmed cell death ligand 1 with the PD-1 (CD279).

9. AstraZeneca shares drop as lung cancer trial update lags ...

   www.aol.com/news/astrazeneca-shares-drop-lung...

   AstraZeneca said on Monday an experimental precision drug slowed progression of lung cancer in a late-stage trial, but the company's shares fell as much as 6% as analysts said the benefits may not ...